Combinations of olmesartan and a calciumchannel blocker or a diuretic inelderly hypertensive patients: A randomized, controlled trial
Toshio Ogihara, Takao Saruta, Hiromi Rakugi, Ikuo Saito et autres
Objective: The aim of the present study was to compare the cardiovascular effects of olmesartan, an angiotensin II receptor blocker, combined with a calcium channel blocker (CCB) or a diuretic, in a prospective, randomized, openlabel, blinded endpoint trial. Methods: Japanese hypertensive patients …
jp (code pays fourni par la source)